|Articles|June 15, 2016
- BioPharm International-06-15-2016
- Volume 2016 ebook
- Issue 1
Biomanufacturers Demand Higher Quality Standards in 2016
Author(s)Eric Langer
Biopharmaceutical manufacturers continue to put quality at the forefront of their relationships.
Advertisement
Quality considerations have always been vital to biotherapeutic developers and CMOs. Yet, in 2016, it seems that these considerations are taking on a new emphasis. One of the main industry trends seen this year-increased attention to continuous bioprocessing-is at least partly driven by the potential for improved product quality.
Download the
.
Articles in this issue
over 9 years ago
Contract Service Providers Gear Up to Develop Emerging Therapiesover 9 years ago
Biopharma Service Providers Address a Full Plate of Challengesover 9 years ago
Dealing with Pharmaceutical Supply-Chain Complexitiesover 9 years ago
Keeping it Simple: Collaborating for Success in Drug Deliveryover 9 years ago
Preventing Phase III Failuresover 9 years ago
Outsourcing Industry Marked by Considerable Investments in 2016Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
2
Biopharma’s Digital Hopes Versus Actual Implementation
3
Check Your Knowledge: Patient-Centric Care Through Oral Liquid Delivery
4
AstraZeneca Lupus Treatment Support in EU Opens Door for Self-Administration Options
5
